Pilot Study Comparing Topical Anesthetic Agents in Pterygium Surgery: Subconjunctival Injection Versus 2% Lidocaine Gel Versus 5% Lidocaine Gel

Pereira, Felipe; Shiroma, Hélio Francisco; Urias, Muller; Yamada, Verônica Haysa; Lima, Acácio; Hofling-Lima, Ana Luísa; Farah, Michel Eid; Rodrigues, Eduardo Büchele

doi:10.1097/ico.0000000000001451

Cited by 6 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pereira et al 6 compared the use of topical lidocaine gel versus subconjunctival lidocaine injection for pterygium surgery and concluded they were equally effective, but topical gel is significantly more well tolerated at initial administration.…”

Section: Resultsmentioning

confidence: 99%

Surgical Techniques and Adjuvants for the Management of Pterygium

Patel

Rhee

2021

Eye &Amp; Contact Lens: Science &Amp; Clinical Practice

View full text Add to dashboard Cite

To provide an updated review of surgical techniques and adjuvants for the management of pterygium. Methods: A literature search was conducted in PubMed for studies published since January 2011. "Pterygium surgery" and the MeSH term "Pterygium/surgery" was used. The results were filtered for randomized controlled trials in English, yielding 60 citations. Results: One study compared topical anesthetic agents. One study compared methods of corneal polishing of the corneoscleral bed after pterygium excision. Numerous studies evaluated the use of conjunctival autograft versus amniotic membrane, superior versus inferior conjunctival autograft, and conjunctival versus limbal-conjunctival autograft. Many studies evaluated graft fixation methods. Several studies evaluated the adjuvant use of mitomycin C, 5-fluorouracil, and bevacizumab. A few studies evaluated the adjuvant use of steroids. Eleven studies evaluated various methods of postoperative management. Conclusions: Current evidence supports pterygium excision with conjunctival autograft fixation using fibrin glue, followed by patching until the first postoperative visit. Surgical adjuvants and postoperative use of artificial tears and topical cyclosporine 0.05% may further reduce recurrence. Postoperative use of topical steroids is highly variable because there is no consensus regarding the optimal dose, frequency, and duration of treatment.

show abstract

Section: Resultsmentioning

confidence: 99%

Surgical Techniques and Adjuvants for the Management of Pterygium

Patel

Rhee

2021

Eye &Amp; Contact Lens: Science &Amp; Clinical Practice

View full text Add to dashboard Cite

show abstract

“…Retrobulbar or peribulbar anesthesia is generally used in patients because it provides relatively better pain control during the surgical procedure [39]. Another alternative is to use subconjunctival anesthesia using lidocaine or proparacaine injection [40]. However, in patients with needle phobia, topical anesthesia with 2% or 5% lidocaine gel may be considered [40], [41].…”

Section: A Surgical Excisionmentioning

confidence: 99%

“…Another alternative is to use subconjunctival anesthesia using lidocaine or proparacaine injection [40]. However, in patients with needle phobia, topical anesthesia with 2% or 5% lidocaine gel may be considered [40], [41].…”

Section: A Surgical Excisionmentioning

confidence: 99%

Updates on the Mechanism and Management of Pterygium: A Brief Review

Sakti¹

2021

EJMED

View full text Add to dashboard Cite

Pterygium is an ocular surface disease characterized by invasive fibrovascular growth due to pathological proliferation and inflammation on the conjunctival and corneal tissue. Its occurrence has been associated with chronic ultraviolet exposure, thus becoming one of the most common eye problems in tropical regions worldwide. Although pterygium rarely causes severe visual disturbances or blindness, it often becomes a distressing problem because of the high recurrence rate and unsatisfactory cosmetic outcomes, despite receiving removal management. In recent decades, studies regarding molecular mechanisms and management of pterygium have been advanced. This review provides a brief update on the mechanism and management to achieve more optimal and satisfactory pterygium therapeutic approaches.

show abstract